Unravelling analgesic nephropathy.
D000082:Acetaminophen / Q000009:adverse effects; D000700:Analgesics / Q000009:adverse effects*; D000818:Animals; D001241:Aspirin / Q000009:adverse effects; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000139:chemically induced; D007681:Kidney Papillary Necrosis / Q000139:chemically induced*; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D010615:Phenacetin / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D012459:Salicylates / Q000009:adverse effects; D013091:Spermatogenesis / Q000187:drug effects; D019966:Substance-Related Disorders
D000700:Analgesics; D012459:Salicylates; D000082:Acetaminophen; D010615:Phenacetin; D001241:Aspirin